Stock listing

OTC:ISCO International Stem Cell Corporation Stock

Follow International Stem Cell Corporation into a list and get an email when it puts out news.

Share price · OTC:ISCO

$0.16 USD +0.00 (+0.3%)

Close on Nov 18, 2026

Past year +6.4% · daily closes, Nov 18, 2025 – Nov 18, 2026, adjusted for splits
Day range
$0.16 – $0.16 USDNov 18, 2026
Volume
1,248 sharesNov 18, 2026
Market cap
$1.28M USDAt the close on Nov 18, 2026 · price × 8.00M shares outstanding
52-week range
$0.12 – $0.54 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
Traded on an average day
$10,481 USDMedian day 3,100 shares · 4 days with no trades · last 3 months, Aug 18, 2026 – Nov 18, 2026
International Stem Cell Corporation logo

Daily closes

Last 3 months, Aug 18, 2026 – Nov 18, 2026 · OTC:ISCO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.16+0.001+0.3%$0.16$0.16$0.161,248
$0.159+0.004+2.6%$0.167$0.167$0.1591,154
$0.1550.000.0%$0.155$0.155$0.15528,563
$0.155+0.01+6.9%$0.159$0.161$0.1555,062
$0.1450.000.0%$0.145$0.145$0.14524,996
$0.145+0.005+3.6%$0.145$0.145$0.145400
$0.140.000.0%$0.14$0.14$0.144
$0.14-0.04-22.2%$0.16$0.18$0.1449,200
$0.18+0.03+20.0%$0.17$0.18$0.172,800
$0.15+0.01+7.1%$0.15$0.16$0.157,000
$0.14-0.01-6.7%$0.14$0.14$0.14400
$0.150.000.0%$0.19$0.19$0.1438,900
$0.15-0.03-16.7%$0.18$0.18$0.14200,400
$0.18-0.08-30.8%$0.26$0.26$0.17242,200
$0.26-0.023-8.1%$0.29$0.29$0.2626,380
$0.283+0.003+1.1%$0.27$0.29$0.2726,456
$0.28+0.01+3.7%$0.28$0.29$0.286,500
$0.27+0.01+3.8%$0.27$0.27$0.276,700
$0.26+0.01+4.0%$0.26$0.26$0.26600
$0.25-0.03-10.7%$0.27$0.29$0.2510,200
$0.280.000.0%$0.28$0.28$0.281,300
$0.28+0.01+3.7%$0.29$0.29$0.28300
$0.27-0.02-6.9%$0.26$0.28$0.26800
$0.29+0.01+3.6%$0.28$0.29$0.284,500
$0.28-0.01-3.4%$0.28$0.29$0.281,200
$0.290.000.0%$0.29$0.29$0.292,500
$0.29-0.01-3.3%$0.29$0.29$0.291,000
$0.30-0.01-3.2%$0.30$0.33$0.309,200
$0.31-0.02-6.1%$0.30$0.31$0.30300
$0.330.000.0%$0.31$0.33$0.303,100
$0.33-0.02-5.7%$0.33$0.33$0.33100
$0.350.000.0%$0.35$0.35$0.350
$0.35+0.03+9.4%$0.32$0.35$0.323,100
$0.32-0.01-3.0%$0.36$0.36$0.32600
$0.330.000.0%$0.34$0.34$0.28155,400
$0.330.000.0%$0.33$0.33$0.330
$0.330.000.0%$0.33$0.33$0.33500
$0.33-0.04-10.8%$0.35$0.35$0.338,300
$0.37+0.05+15.6%$0.35$0.37$0.35500
$0.32-0.06-15.8%$0.37$0.37$0.3251,900
$0.38+0.02+5.6%$0.44$0.52$0.34460,300
$0.360.000.0%$0.32$0.36$0.3234,000
$0.36-0.01-2.7%$0.40$0.45$0.3628,600
$0.37+0.04+12.1%$0.40$0.53$0.3655,000
$0.33-0.09-21.4%$0.33$0.33$0.33100
$0.420.000.0%$0.42$0.42$0.420
$0.42+0.03+7.7%$0.42$0.42$0.42300
$0.39+0.01+2.6%$0.31$0.40$0.312,500
$0.380.000.0%$0.38$0.38$0.380
$0.38+0.03+8.6%$0.36$0.38$0.3011,900
$0.35-0.14-28.6%$0.35$0.43$0.21322,800
$0.490.000.0%$0.49$0.49$0.422,100
$0.49+0.01+2.1%$0.49$0.49$0.49200
$0.48-0.02-4.0%$0.48$0.48$0.481,000
$0.500.000.0%$0.46$0.50$0.464,600
$0.50+0.05+11.1%$0.40$0.50$0.3051,500
$0.45-0.06-11.8%$0.46$0.46$0.421,400
$0.51+0.02+4.1%$0.51$0.54$0.4517,000
$0.49+0.09+22.5%$0.40$0.52$0.3793,000

Splits

1 split · OTC:ISCO · every price before a split is adjusted for it

DayRatioWhat
1-for-150Consolidation
Ticker
OTC:ISCO
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

International Stem Cell Corporation on 6ix

Sector
Health care
Industry
Biotechnology
Decks
4 decks · latest Nov 27, 2019

Valuation

EV/sales −2.0× against a median of 29.8×: 2nd lowest of 5 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 18, 2026

Enterprise value
−$18.76M USD
P/E
0.1×
EV/sales
−2.0×
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
54.5%
Operating margin
−6.4%
Net margin
222.6%
Debt to equity
0.0×
Beta vs S&P 500
-0.52

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
International Stem Cell Corporation · OTC:ISCOUS$1.28M−US$18.76M0.1×−2.0×n/a0.1×222.6%0.0×-0.52
Jupiter Neurosciences, Inc. · NASDAQ:JUNSUS$1.63MUS$1.33Mn/a16.9×n/an/an/an/a1.88
Kairos Pharma, Ltd. · AMEX:KAPAUS$1.48M−US$1.65Mn/an/an/a0.4×n/a0.0×1.36
BioRestorative Therapies, Inc. · NASDAQ:BRTXUS$1.45M−US$2.11Mn/a−5.9×n/a0.5×n/a0.0×1.81
Nutra Pharma Corp. · OTC:NPHCUS$1.43MUS$13.99Mn/a87.0×n/an/an/an/an/a
Aptevo Therapeutics Inc. · NASDAQ:APVOUS$1.40M−US$2.88Mn/an/an/a0.4×n/a1.0×0.93
Agentix Corp. · OTC:AGTXUS$1.35MUS$1.34Mn/an/an/an/an/an/a-0.73
Clearmind Medicine Inc. · NASDAQ:CMNDUS$1.33M−US$9.01Mn/an/an/a0.2×n/a0.0×0.29
Artelo Biosciences, Inc. · NASDAQ:ARTLUS$1.30MUS$1.34Mn/an/an/a0.2×n/a0.0×1.36
SureNano Science Ltd · CSE:SUREUS$1.17MUS$672,335n/an/an/a0.3×n/a0.0×0.25
Valion Bio, Inc. · NASDAQ:VBIOUS$1.04MUS$16.34Mn/a42.8×n/a0.2×n/a4.1×1.11
Median of the othersUS$1.37MUS$1.00M29.8×0.3×0.0×1.11

Team and board

Officers

OfficerRole
Andrey SemechkinChief Executive Officer & Co-Chairman of the Board
Russell KernExecutive Vice President, Chief Scientific Officer & Principal Financial Officer

Board

DirectorRole
Andrey SemechkinChief Executive Officer & Co-Chairman of the Board
Donald WrightCo-Chairman
Paul MaierIndependent Director
Russell KernExecutive Vice President, Chief Scientific Officer & Principal Financial Officer

Events

QuarterResultsShare move
Q2 2025Aug 14, 20250.0%
Q1 2025Jun 11, 2025 · After close0.0%
Q4 2024Feb 26, 20250.0%
Q3 2024Nov 29, 2024+11.1%
Q2 2024Aug 14, 20240.0%
Q1 2024May 14, 2024 · After close0.0%
Q3 2023Nov 16, 20230.0%
Q2 2023Aug 16, 20230.0%
Q1 2023Apr 11, 2023−9.1%
Q3 2022Nov 14, 2022 · After close0.0%
All 17 quarters
QuarterResultsShare move
Q2 2022Aug 12, 2022 · Before open−18.4%
Q1 2022May 20, 2022−10.0%
Q4 2021Mar 2, 20220.0%
Quarter to Sep 30, 2021Nov 18, 20210.0%
Quarter to Jun 30, 2021Aug 18, 20210.0%
Quarter to Mar 31, 2021May 14, 2021−11.1%
Quarter to Dec 31, 2020Mar 30, 2021 · After close0.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2019)Investor deck16 slidesNov 27, 2019
Investor Presentation (October 2018)Investor deck19 slidesOctober 2018
Investor Presentation (December 2015)Investor deck12 slidesDec 17, 2015
Investor Presentation (January 2014)Investor deck22 slidesJan 21, 2014

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue9.10M9.09M7.79M8.18M7.18M7.13M9.47M11.1M7.46M7.17M
Cost of revenue4.03M3.76M3.18M3.27M2.94M2.78M3.93M4.07M2.12M1.94M
Gross profit5.07M5.32M4.61M4.91M4.24M4.35M5.54M7.02M5.33M5.22M
Research and development684.0K657.0K511.0K492.0K695.0K988.0K1.39M2.40M2.66M2.86M
Operating income-267.0K-68.0K-663.0K-183.0K-1.92M-2.82M-5.73M-3.47M-4.94M-4.85M
Depreciation and amortization219.0K206.0K194.0K218.0K262.0K253.0K285.0K308.0K326.0K331.0K
EBITDA-48.0K138.0K-469.0K35.0K-1.66M-2.56M-5.44M-3.17M-4.62M-4.52M
Interest expense151.0K145.0K139.0K135.0K128.0K113.0K77.0K48.0K59.0K6.00K
Income before tax-418.0K-209.0K-131.0K-331.0K-2.13M-6.07M-1.08M
Income tax00000
Net income-418.0K-209.0K-131.0K-331.0K-899.0K-2.72M-4.26M-2.13M-6.07M-1.08M
Earnings per share, basic-0.05-0.03-0.02-0.04-0.11-0.36-0.57-0.33-1.46-0.34
Earnings per share, diluted-0.05-0.03-0.02-0.04-0.11-0.36-0.57-0.33-1.46-0.34

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents793.0K1.23M1.59M742.0K171.0K689.0K484.0K1.07M304.0K110.0K
Receivables5.00K1.06M574.0K747.0K844.0K403.0K1.51M651.0K465.0K574.0K
Inventory100.0K1.15M1.26M1.38M1.18M917.0K1.25M1.50M1.31M1.39M
Current assets3.41M3.56M3.52M2.96M2.33M2.18M3.45M3.77M2.85M2.49M
Property, plant and equipment21.0K257.0K215.0K248.0K384.0K534.0K668.0K469.0K321.0K396.0K
Total assets4.82M5.17M5.39M5.13M4.95M5.29M6.62M7.80M6.86M7.04M
Accounts payable109.0K186.0K364.0K322.0K508.0K360.0K654.0K458.0K830.0K841.0K
Current liabilities4.58M4.69M4.83M4.63M4.28M1.48M1.91M5.08M4.80M3.60M
Total liabilities4.58M4.80M5.28M5.36M5.23M5.32M5.21M5.26M4.80M
Shareholders' equity-4.06M-3.93M-4.19M-4.52M-4.59M-4.33M-2.89M2.54M2.06M3.44M
Shares outstanding8.00M8.00M8.00M8.00M8.00M7.54M7.54M6.93M6.06M3.95M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations8.00K13.0K929.0K332.0K-1.30M-341.0K-1.40M-1.08M-2.14M-4.20M
Capital spending-43.0K-166.0K-80.0K-1.00K-23.0K-28.0K-164.0K-185.0K-112.0K-231.0K
Free cash flow-35.0K-153.0K849.0K331.0K-1.32M-369.0K-1.56M-1.27M-2.25M-4.43M
Cash from investing-45.0K-171.0K-83.0K-11.0K-45.0K-108.0K-494.0K-661.0K-864.0K-943.0K
Cash from financing-200.0K-200.0K250.0K824.0K654.0K1.30M2.51M3.20M4.72M
Change in cash-237.0K-358.0K846.0K571.0K-518.0K205.0K-591.0K771.0K194.0K-422.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 20, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeNov 17, 2026Explanation requestSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
8-K · Current reportSep 8, 2026Acquisition or disposalSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
DEF 14CAug 4, 2026Meeting noticeSEC
PRE 14CJul 24, 2026Meeting noticeSEC
8-K · Current reportJul 15, 2026Material contractSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
8-K · Current reportJun 12, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
10-K · Annual reportMar 30, 2026Annual reportSEC
8-K · Current reportNov 18, 2025Meeting outcomeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportSep 16, 2025Material contractSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
4 · Change in ownershipJun 20, 2025Insider tradeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
ARS · Annual report to shareholdersApr 24, 2025Annual reportSEC
DEF 14A · Proxy statementApr 24, 2025Meeting noticeSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
8-K · Current reportSep 16, 2024Material contractSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
4 · Change in ownershipJun 13, 2024Insider tradeSEC
10-Q · Quarterly reportMay 14, 2024Quarterly reportSEC
ARS · Annual report to shareholdersApr 26, 2024Annual reportSEC
DEF 14A · Proxy statementApr 25, 2024Meeting noticeSEC
S-8 · Registration statement for employee plansMar 28, 2024Offer documentSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
4 · Change in ownershipNov 8, 2023Insider tradeSEC
4 · Change in ownershipNov 8, 2023Insider tradeSEC
DEF 14CSep 27, 2023Meeting noticeSEC
8-K · Current reportSep 18, 2023Material contractSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
8-K · Current reportJun 21, 2023Meeting outcomeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
10-Q · Quarterly reportMay 12, 2023Quarterly reportSEC
ARS · Annual report to shareholdersApr 28, 2023Annual reportSEC
DEF 14A · Proxy statementApr 28, 2023Meeting noticeSEC
10-K · Annual reportMar 30, 2023Annual reportSEC
8-K · Current reportMar 16, 2023Material contractSEC
10-Q · Quarterly reportNov 14, 2022Quarterly reportSEC
8-K · Current reportSep 16, 2022Material contractSEC
10-Q · Quarterly reportAug 12, 2022Quarterly reportSEC
8-K · Current reportJun 13, 2022Meeting outcomeSEC
4 · Change in ownershipJun 10, 2022Insider tradeSEC
4 · Change in ownershipJun 10, 2022Insider tradeSEC
10-Q · Quarterly reportMay 13, 2022Quarterly reportSEC
8-K · Current reportApr 29, 2022Management or board changeSEC
DEF 14A · Proxy statementApr 27, 2022Meeting noticeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
4 · Change in ownershipApr 26, 2022Insider tradeSEC
10-K · Annual reportMar 29, 2022Annual reportSEC
8-K · Current reportMar 3, 2022Material contractSEC
8-K · Current reportFeb 1, 2022Management or board changeSEC
8-K · Current reportJan 14, 2022Material contractSEC
8-K · Current reportDec 28, 2021Current reportSEC
10-Q · Quarterly reportNov 12, 2021Quarterly reportSEC
8-K · Current reportNov 1, 2021Material contractSEC
10-Q · Quarterly reportAug 13, 2021Quarterly reportSEC
8-K · Current reportJun 30, 2021Current reportSEC
8-K · Current reportJun 14, 2021Meeting outcomeSEC
4 · Change in ownershipJun 11, 2021Insider tradeSEC
4 · Change in ownershipJun 11, 2021Insider tradeSEC
4 · Change in ownershipJun 11, 2021Insider tradeSEC
4 · Change in ownershipJun 11, 2021Insider tradeSEC
4 · Change in ownershipJun 11, 2021Insider tradeSEC
10-Q · Quarterly reportMay 14, 2021Quarterly reportSEC
DEF 14A · Proxy statementApr 29, 2021Meeting noticeSEC
10-K · Annual reportMar 30, 2021Annual reportSEC
8-K · Current reportMar 8, 2021Material contractSEC
8-K · Current reportJan 19, 2021Material contractSEC
10-Q · Quarterly reportNov 12, 2020Quarterly reportSEC
10-Q · Quarterly reportAug 12, 2020Quarterly reportSEC
8-K · Current reportJun 29, 2020Meeting outcomeSEC
4/A · Change in ownership, amendedJun 26, 2020Insider tradeSEC
4/A · Change in ownership, amendedJun 26, 2020Insider tradeSEC
4 · Change in ownershipJun 24, 2020Insider tradeSEC
4 · Change in ownershipJun 24, 2020Insider tradeSEC
10-Q · Quarterly reportJun 19, 2020Quarterly reportSEC
DEF 14A · Proxy statementJun 1, 2020Meeting noticeSEC
10-K · Annual reportMay 29, 2020Annual reportSEC
8-K · Current reportMay 13, 2020Current reportSEC
NT 10-K · Late filing noticeMay 13, 2020Explanation requestSEC
8-K · Current reportApr 28, 2020Current reportSEC
8-K · Current reportMar 30, 2020Current reportSEC
8-K · Current reportDec 19, 2019Material contractSEC
10-Q · Quarterly reportNov 12, 2019Quarterly reportSEC
10-Q · Quarterly reportAug 26, 2019Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2019Explanation requestSEC
8-K · Current reportJul 30, 2019Current reportSEC
8-K · Current reportJun 7, 2019Meeting outcomeSEC
4 · Change in ownershipJun 5, 2019Insider tradeSEC
4 · Change in ownershipJun 5, 2019Insider tradeSEC
10-Q · Quarterly reportMay 15, 2019Quarterly reportSEC
DEF 14A · Proxy statementApr 30, 2019Meeting noticeSEC
8-K · Current reportApr 23, 2019Material contractSEC
4 · Change in ownershipApr 22, 2019Insider tradeSEC
10-K · Annual reportApr 12, 2019Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2019Explanation requestSEC
SC 13D/A · Big-stake notice, amendedMar 6, 2019Big-stake noticeSEC
4 · Change in ownershipMar 4, 2019Insider tradeSEC
4 · Change in ownershipMar 4, 2019Insider tradeSEC
4 · Change in ownershipMar 4, 2019Insider tradeSEC
8-K · Current reportJan 23, 2019Material contractSEC
4 · Change in ownershipJan 22, 2019Insider tradeSEC
4 · Change in ownershipDec 6, 2018Insider tradeSEC
4 · Change in ownershipDec 6, 2018Insider tradeSEC
8-K · Current reportNov 14, 2018Material contractSEC
10-Q · Quarterly reportNov 14, 2018Quarterly reportSEC
4 · Change in ownershipOct 3, 2018Insider tradeSEC
8-K · Current reportOct 3, 2018FinancingSEC
4/A · Change in ownership, amendedSep 27, 2018Insider tradeSEC
4/A · Change in ownership, amendedSep 27, 2018Insider tradeSEC
4/A · Change in ownership, amendedSep 27, 2018Insider tradeSEC
4 · Change in ownershipAug 22, 2018Insider tradeSEC
4 · Change in ownershipAug 21, 2018Insider tradeSEC
4/A · Change in ownership, amendedAug 21, 2018Insider tradeSEC
4/A · Change in ownership, amendedAug 21, 2018Insider tradeSEC
4 · Change in ownershipAug 17, 2018Insider tradeSEC
4 · Change in ownershipAug 17, 2018Insider tradeSEC
4 · Change in ownershipAug 17, 2018Insider tradeSEC
S-8 · Registration statement for employee plansAug 15, 2018Offer documentSEC
10-Q · Quarterly reportAug 14, 2018Quarterly reportSEC
4 · Change in ownershipJul 17, 2018Insider tradeSEC
4 · Change in ownershipJul 12, 2018Insider tradeSEC
4 · Change in ownershipJun 28, 2018Insider tradeSEC
4 · Change in ownershipJun 27, 2018Insider tradeSEC
8-K · Current reportJun 27, 2018Meeting outcomeSEC
4 · Change in ownershipJun 25, 2018Insider tradeSEC
4 · Change in ownershipJun 25, 2018Insider tradeSEC
4 · Change in ownershipJun 25, 2018Insider tradeSEC
8-K · Current reportJun 4, 2018Material contractSEC
10-Q · Quarterly reportMay 21, 2018Quarterly reportSEC
4 · Change in ownershipMay 16, 2018Insider tradeSEC
8-K · Current reportMay 16, 2018Material contractSEC
NT 10-Q · Late filing noticeMay 15, 2018Explanation requestSEC
DEF 14A · Proxy statementApr 30, 2018Meeting noticeSEC
10-K · Annual reportApr 6, 2018Annual reportSEC
4 · Change in ownershipApr 4, 2018Insider tradeSEC
4 · Change in ownershipApr 3, 2018Insider tradeSEC
4 · Change in ownershipApr 3, 2018Insider tradeSEC
NT 10-K · Late filing noticeApr 2, 2018Explanation requestSEC
4 · Change in ownershipMar 14, 2018Insider tradeSEC
4 · Change in ownershipMar 14, 2018Insider tradeSEC
8-K · Current reportMar 8, 2018Material contractSEC
RW · Request to withdraw a registrationMar 8, 2018Other filingsSEC
4 · Change in ownershipFeb 22, 2018Insider tradeSEC
4 · Change in ownershipFeb 22, 2018Insider tradeSEC
8-K · Current reportFeb 21, 2018Management or board changeSEC
4 · Change in ownershipFeb 1, 2018Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJan 31, 2018Big-stake noticeSEC
4 · Change in ownershipJan 2, 2018Insider tradeSEC
4 · Change in ownershipJan 2, 2018Insider tradeSEC
4 · Change in ownershipJan 2, 2018Insider tradeSEC
8-K · Current reportDec 13, 2017Material contractSEC
4 · Change in ownershipDec 12, 2017Insider tradeSEC
4 · Change in ownershipDec 8, 2017Insider tradeSEC
4 · Change in ownershipDec 8, 2017Insider tradeSEC
10-Q · Quarterly reportNov 13, 2017Quarterly reportSEC
4 · Change in ownershipOct 2, 2017Insider tradeSEC
4 · Change in ownershipOct 2, 2017Insider tradeSEC
4 · Change in ownershipOct 2, 2017Insider tradeSEC
8-K · Current reportSep 6, 2017Material contractSEC
4 · Change in ownershipAug 30, 2017Insider tradeSEC
3 · Initial statement of ownershipAug 30, 2017Insider tradeSEC
8-K · Current reportAug 25, 2017Management or board changeSEC
10-Q · Quarterly reportAug 11, 2017Quarterly reportSEC
4 · Change in ownershipJul 5, 2017Insider tradeSEC
4 · Change in ownershipJul 5, 2017Insider tradeSEC
4 · Change in ownershipJul 5, 2017Insider tradeSEC
EFFECT · Notice that a registration is effectiveJun 15, 2017Other filingsSEC
POS AM · Amendment to an effective registrationJun 9, 2017Offer documentSEC
8-K · Current reportJun 8, 2017Material contractSEC
8-K · Current reportJun 6, 2017Meeting outcomeSEC
4 · Change in ownershipJun 2, 2017Insider tradeSEC
4 · Change in ownershipJun 2, 2017Insider tradeSEC
4 · Change in ownershipJun 2, 2017Insider tradeSEC
4 · Change in ownershipJun 1, 2017Insider tradeSEC
4 · Change in ownershipJun 1, 2017Insider tradeSEC
4 · Change in ownershipJun 1, 2017Insider tradeSEC
4 · Change in ownershipJun 1, 2017Insider tradeSEC
4 · Change in ownershipMay 24, 2017Insider tradeSEC
10-Q · Quarterly reportMay 15, 2017Quarterly reportSEC
DEF 14A · Proxy statementApr 27, 2017Meeting noticeSEC
4 · Change in ownershipApr 3, 2017Insider tradeSEC
4 · Change in ownershipApr 3, 2017Insider tradeSEC
4 · Change in ownershipApr 3, 2017Insider tradeSEC
10-K · Annual reportMar 31, 2017Annual reportSEC

This page holds 200 of 827 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from International Stem Cell Corporation’s releases · as of Jun 30, 2026

Common shares
8,004,389
Fully diluted
8,004,389

Fully diluted

LineSharesAs of
Common shares8,004,389Jun 30, 2026

Share count over time

CountShares
Jun 30, 20268,004,389

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul V. Maier
Other companies: Eton Pharmaceuticals, Inc. (Eton Pharmaceutical Audit Committee Chairman · Since at least Nov 9, 2018); Ambrx Biopharma Inc. (Director · Jan 1, 2023 – Mar 7, 2024 · Past); AIxCrypto Holdings, Inc. (Director · Jun 24, 2015 – Jan 15, 2020 · Past); MabVax Therapeutics Holdings Inc (Director · Apr 2, 2015 – Apr 2, 2018 · Past); Apricus Biosciences Inc (Director · Jun 1, 2012 – Jan 4, 2018 · Past); Talon Therapeutics Inc (Director · Apr 1, 2011 – Jul 17, 2013 · Past); Sequenom Inc (Chief Financial Officer · Nov 10, 2009 – Feb 10, 2014 · Past); PURE Bioscience (Director · Jan 22, 2008 – Jul 31, 2012 · Past); Ligand Pharmaceuticals Incorporated (Sr. V-P, CFO · Mar 10, 2006 – Nov 20, 2006 · Past)
Independent Director · Since at least Jul 19, 2007
Charles J. Casamento
Other companies: GT Biopharma, Inc. (Independent Director · Since at least May 1, 2023); Eton Pharmaceuticals, Inc. (Director · Since at least Nov 9, 2018); Relmada Therapeutics, Inc. (Chairman of the Board · Since at least Oct 20, 2017); PaxMedica, Inc. (Director · Oct 1, 2022 – Mar 12, 2024 · Past); GridAI Technologies Corp. (Director · Mar 3, 2017 – Jan 2, 2024 · Past)
Director · Mar 31, 2016 – Jun 21, 2018 · Past
Timothy P. Halter
Other companies: DXP Enterprises, Inc. (Director · Since at least Dec 31, 2005); Planet Green Holdings Corp. (CEO, President, CFO and COO, Director · Apr 10, 2007 – Apr 10, 2007 · Past); Sutor Technology Group Ltd (CEO, President, CFO & COO, Director · Nov 3, 2006 – Nov 3, 2006 · Past); China Ritar Power Corp (CEO, Pres, CFO, Chairman & Sec, Director · Jun 30, 2006 – Jun 30, 2006 · Past)
CEO, Pres, CFO, Chairman & Sec, Director · Jun 5, 2006 – Jun 5, 2006 · Past
Brian Lundstrom
Other companies: ACADIA Pharmaceuticals Inc. (Sr. VP, Bus. Development · Mar 10, 2006 – Mar 7, 2008 · Past)
President · Nov 5, 2009 – Dec 17, 2010 · Past
Edward O Hunter
Other companies: GEE Group Inc. (Director · Feb 23, 2009 – Feb 23, 2009 · Past)
Director · Jul 19, 2007 – Dec 29, 2008 · Past
James H Berglund
Other companies: Accredited Home Lenders Holding Co (Director · Oct 12, 2007 – Oct 12, 2007 · Past)
Director · Mar 9, 2012 – Jun 20, 2013 · Past
Kenneth C Aldrich
Other companies: Green Dot Corporation (Director · Jul 21, 2010 – May 26, 2021 · Past)
Director · Dec 28, 2006 – Feb 7, 2011 · Past
Linh T Nguyen
Other companies: International Lottery & Totalizator Systems Inc (Chief Financial Officer · Feb 19, 2008 – Feb 19, 2008 · Past)
Chief Financial Officer · Oct 3, 2011 – Apr 9, 2013 · Past
Andrey SemechkinChief Executive Officer & Co-Chairman of the Board · Since at least Dec 30, 2008
Donald WrightCo-Chairman · Since at least Nov 5, 2026
All 21 people
PersonSeat
Edmund R WoodCFO · Jun 30, 2009 – Mar 2, 2011 · Past
Jeff KrstichChief Executive Officer · Dec 28, 2006 – Dec 28, 2006 · Past
Jeffrey JanusDirector · Dec 28, 2006 – May 31, 2012 · Past
Jennifer StephensActing Chief Financial Officer · Aug 25, 2017 – Aug 25, 2017 · Past
John Simon CrawExecutive Vice President · May 29, 2012 – Mar 12, 2015 · Past
Mahnaz EbrahimiChief Financial Officer · May 17, 2016 – May 31, 2017 · Past
Russell KernExecutive Vice President, Chief Scientific Officer & Principal Financial Officer · Since at least Sep 23, 2008
Sophia GarnetteVP, Legal Affairs & Operations · Aug 4, 2014 – Jun 9, 2021 · Past
Tibor Jay NovakChief Financial Officer · Apr 15, 2013 – Nov 10, 2014 · Past
William B AdamsChief Financial Officer · Dec 28, 2006 – Dec 29, 2008 · Past
Wright DonDirector · Since at least Dec 29, 2008

Open People

Log in to ask 6ix AI your own questions about International Stem Cell Corporation.